Previously, we reported data suggesting a difference in the level of SMN protein expression between SMA subjects and control subjects in cultured fibroblasts [27] and Epstein–Barr virus transformed B cells [28]. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.